Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls
- PMID: 23640557
- PMCID: PMC3705658
Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls
Abstract
Background & objectives: ADAM33 is a member of a family of genes that encode membrane-anchored proteins with a disintegrin and a metalloprotease domain, primarily expressed in lung fibroblasts and bronchial smooth muscle cells. ADAM33 has been identified as a risk factor for asthma and is known as a gene associated with airway remodelling. The present study was conducted with the aims to investigate the expression of ADAM33 protein in patients of asthma and non-asthmatic controls, and to assess if the expression of ADAM33 protein relates with severity of asthma.
Methods: A total of 35 subjects, including 27 patients with asthma and eight non-asthmatic controls were included using Global Initiative for Asthma guidelines 2005. Bronchial biopsy tissues were collected and paraffin sections were made to store all study samples. Immunohistochemistry was performed using standardized protocol.
Results: An increase in expression of ADAM33 protein was observed in the epithelium, smooth muscle and mesenchymal cells of asthma cases when compared to controls but there was no relationship with severity of asthma.
Interpretation & conclusions: A higher expression of ADAM33 protein was seen in asthma patients compared to controls. Large prospective studies need to be done with adequate study design to confirm these preliminary finding.
Figures
Comment in
-
Unravelling the role of ADAM 33 in asthma.Indian J Med Res. 2013 Mar;137(3):447-50. Indian J Med Res. 2013. PMID: 23640552 Free PMC article. No abstract available.
Similar articles
-
Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.Respir Res. 2019 Feb 21;20(1):38. doi: 10.1186/s12931-019-1006-1. Respir Res. 2019. PMID: 30791911 Free PMC article.
-
ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma.Mediators Inflamm. 2014;2014:572025. doi: 10.1155/2014/572025. Epub 2014 Apr 10. Mediators Inflamm. 2014. PMID: 24817794 Free PMC article. Review.
-
ADAM33 expression in asthmatic airways and human embryonic lungs.Am J Respir Crit Care Med. 2005 May 1;171(9):958-65. doi: 10.1164/rccm.200409-1251OC. Epub 2005 Feb 11. Am J Respir Crit Care Med. 2005. PMID: 15709049
-
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells.J Allergy Clin Immunol. 2008 Jun;121(6):1393-9, 1399.e1-14. doi: 10.1016/j.jaci.2008.02.031. Epub 2008 Apr 21. J Allergy Clin Immunol. 2008. PMID: 18423563
-
Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells.J Allergy Clin Immunol. 2007 Jan;119(1):89-97. doi: 10.1016/j.jaci.2006.08.038. Epub 2006 Oct 23. J Allergy Clin Immunol. 2007. PMID: 17208589
Cited by
-
Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.Respir Res. 2019 Feb 21;20(1):38. doi: 10.1186/s12931-019-1006-1. Respir Res. 2019. PMID: 30791911 Free PMC article.
-
Association study on ADAM33 polymorphisms in mite-sensitized persistent allergic rhinitis in a Chinese population.PLoS One. 2014 Apr 21;9(4):e95033. doi: 10.1371/journal.pone.0095033. eCollection 2014. PLoS One. 2014. PMID: 24751681 Free PMC article.
-
Unravelling the role of ADAM 33 in asthma.Indian J Med Res. 2013 Mar;137(3):447-50. Indian J Med Res. 2013. PMID: 23640552 Free PMC article. No abstract available.
-
Associations of genetic variants in ADAM33 and TGF-β1 genes with childhood asthma risk.Biomed Rep. 2014 Jul;2(4):533-538. doi: 10.3892/br.2014.280. Epub 2014 May 19. Biomed Rep. 2014. PMID: 24944803 Free PMC article.
-
ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma.Mediators Inflamm. 2014;2014:572025. doi: 10.1155/2014/572025. Epub 2014 Apr 10. Mediators Inflamm. 2014. PMID: 24817794 Free PMC article. Review.
References
-
- Cookson WO, Moffatt MF. Genetics of asthma and allergic disease. Hum Mol Genet. 2000;9:2359–64. - PubMed
-
- Global Initiative for Asthma (Gina), National Heart, Lung and Blood Institute, US Department of Health and Human Services: National Institute of Health (NIH) Publication No 02-3659 (2005) Available from: http://www.ginasthma.org/Guidelines/guidelines-resources.html .
-
- Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000;16:83–7. - PubMed
-
- Yoshinaka T, Nishii K, Yamada K, Sawada H, Nishiwaki E, Smith K, et al. Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene. 2002;282:227–36. - PubMed